Atlas Trials

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

Clinical trial NCT00968253 · COMPLETED

Trial details

NCT number
NCT00968253
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeukemiaAcute Lymphocytic Leukemia
Start date
2009-11-01
Primary completion
2015-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.